Observational multicohort bioinformatic analysis reveals a glycolysis lactate HIF1α angiogenesis coupling axis associated with enzalutamide resistant prostate cancer

Enzalutamide resistance is the principal cause of treatment failure in advanced prostate cancer. Aberrant vasculature and glycolytic reprogramming are implicated, but human evidence linking them remains fragmented. In this observational computational study, we profiled enzalutamide-resistant C4-2B cells (GSE64143), 497 TCGA-PRAD primary tumors and 266 metastatic castration-resistant prostate cancer (mCRPC) samples (SU2C/PCF, pooled abiraterone and enzalutamide exposure), with validation in the MSKCC and GSE70768 cohorts, protein-level data and metastatic single-cell RNA sequencing (GSE297652). In resistant cells, hypoxia and glycolysis were the top activated programs while androgen response was suppressed. Hypoxia, glycolysis and angiogenesis scores were strongly coupled in primary tumors but predicted overall survival only in mCRPC (glycolysis HR = 11.7), defining a boundary condition: this axis is prognostic only in treated, advanced disease. Network-pharmacology analysis positioned the Qi-Bi-Yin (QBD) target HIF1A within this axis, and bidirectional in silico perturbation indicated that BCL2 and HIF1A differentially influence axis integrity. Connectivity-map screening and ChEMBL bioactivity mining nominated candidate compounds for experimental follow-up (e.g. the NAMPT inhibitor FK-866; formononetin–BCL2 Ki = 10 nM). Taken together, these observational findings point to a metabolic–vascular coupling axis and suggest potential therapeutic targets requiring experimental validation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-14
DOI
https://doi.org/10.1007/s12672-026-06308-y
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Observational multicohort bioinformatic analysis reveals a glycolysis lactate HIF1α angiogenesis coupling axis associated with enzalutamide resistant prostate cancer

Haojian Zhang, Ting Xiao
Discover Oncology
Prostate Cancer Treatment and Research
article

Observational multicohort bioinformatic analysis reveals a glycolysis lactate HIF1α angiogenesis coupling axis associated with enzalutamide resistant prostate cancer

Haojian Zhang, Ting Xiao
article en

Abstract

Enzalutamide resistance is the principal cause of treatment failure in advanced prostate cancer. Aberrant vasculature and glycolytic reprogramming are implicated, but human evidence linking them remains fragmented. In this observational computational study, we profiled enzalutamide-resistant C4-2B cells (GSE64143), 497 TCGA-PRAD primary tumors and 266 metastatic castration-resistant prostate cancer (mCRPC) samples (SU2C/PCF, pooled abiraterone and enzalutamide exposure), with validation in the MSKCC and GSE70768 cohorts, protein-level data and metastatic single-cell RNA sequencing (GSE297652). In resistant cells, hypoxia and glycolysis were the top activated programs while androgen response was suppressed. Hypoxia, glycolysis and angiogenesis scores were strongly coupled in primary tumors but predicted overall survival only in mCRPC (glycolysis HR = 11.7), defining a boundary condition: this axis is prognostic only in treated, advanced disease. Network-pharmacology analysis positioned the Qi-Bi-Yin (QBD) target HIF1A within this axis, and bidirectional in silico perturbation indicated that BCL2 and HIF1A differentially influence axis integrity. Connectivity-map screening and ChEMBL bioactivity mining nominated candidate compounds for experimental follow-up (e.g. the NAMPT inhibitor FK-866; formononetin–BCL2 Ki = 10 nM). Taken together, these observational findings point to a metabolic–vascular coupling axis and suggest potential therapeutic targets requiring experimental validation.

Discover Oncology
Tianjin University of Traditional Chinese Medicine (CN), First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Good health and well-being
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Observational multicohort bioinformatic analysis reveals a glycolysis lactate HIF1α angiogenesis coupling axis associated with enzalutamide resistant prostate cancer — Haojian Zhang, Ting Xiao · Discover Oncology (2026) | TGRS Research Map | TGRS